View Older Stories View More Recent Stories

Apr 7, 2014 11:57AM Streetinsider.com's Hot Lunchtime Reads 04/07: (KR) (MSFT) (SRPT) (MDVN)
Apr 7, 2014 11:14AM Pre-Clinical Data for MEI Pharma's (MEIP) Pracinostat Will Set Development Tone - Roth Capital
Apr 7, 2014 11:01AM American Apparel (APP) Price Target Reduced to $0.75 at Roth
Apr 4, 2014 12:11PM Roth Affirms Hydrogenics (HYGS) at 'Bur'; Customer-Driven Hiccup Doesn't Affect Overall Thesis
Apr 4, 2014 08:34AM Ocean Power Technologies (OPTT) Prices 3.8M Offering at $3.10/sh
Apr 4, 2014 08:30AM Ocean Power Technologies Prices Underwritten Public Offering of Common Stock
Apr 4, 2014 08:12AM Roth Capital Starts Energy Fuels (UUUU) at Buy
Apr 4, 2014 07:17AM Roth Capital Starts Uranium Resources (URRE) at Buy
Apr 3, 2014 04:39PM Ocean Power Technologies, Inc. (OPTT) Plans Common Stock Offering
Apr 3, 2014 04:29PM Ocean Power Technologies Announces Proposed Public Offering of Common Stock
Apr 3, 2014 04:01PM SolarCity (SCTY) ABS Offerings are Evolutionary Step Toward Lower-Cost Financing - Roth
Apr 3, 2014 04:01PM AGTC Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Apr 3, 2014 09:02AM Catyalyst Pharma (CPRX) Prices 11.33M Common Offering at $2.21/Share
Apr 2, 2014 04:04PM Endocyte (ECYT) Closes 5.18M Offering; Sees Net Proceeds of $101.8M
Apr 2, 2014 04:01PM Endocyte, Inc. Closes Public Offering of Common Stock
Apr 2, 2014 08:45AM Roth Affirms Keryx (KERX) at 'Buy'; ESRD Overhang Removed
Apr 1, 2014 11:23AM Roth Lifts PT on Stemline (STML) to $62; Sees 'Pivotal' Year in 2014
Apr 1, 2014 09:50AM Roth Sees Regeneron/Sanofi Alirocumab Phase 2 Results as Positive; Maintains 'Buy' Rating (REGN)
Apr 1, 2014 08:40AM Clean Diesel (CDTI) Announces $6.9M Equity Raise
Apr 1, 2014 08:38AM CDTi to Raise Approximately $6.9 Million
Apr 1, 2014 07:47AM Roth Capital Positive on Palatin (PTN) Granting Bremelanotide Extension
Mar 31, 2014 01:59PM Roth Raises PT on Regeneron (REGN) to $382; ODYSSEY MONO, Alirocumab Data Bolsters Positive Outlook
Mar 31, 2014 01:49PM Regeneron Pharma (REGN) PT Raised to $382 at Roth Capital
Mar 31, 2014 08:39AM Roth Boosts PT on Curis (CRIS) to $10; '427 Overhang Now Lifted
Mar 28, 2014 02:05PM Notable 52-Week Highs and Lows of the Day 03/28: (AA) (ELY) (INVN) High; (EXEL) (SPEX) Low
Mar 28, 2014 11:24AM Notable Analyst Rating Changes 03/28: (SCTY) (CTSH) (INVN) Upgraded; (PNW) (CIEN) (PCG) Downgraded
Mar 28, 2014 09:22AM Cytokinetics (CYTK) Starts COSMIC-HF Phase II Enrollment; BENEFIT-ALS Still in Focus - Roth
Mar 28, 2014 07:17AM Endocyte (ECYT) Prices 4.5M Share Offering at $21
Mar 28, 2014 07:12AM Roth Capital Upgrades InvenSense (INVN) to Buy
Mar 27, 2014 06:48PM Endocyte, Inc. Prices Public Offering of Common Stock
Mar 27, 2014 10:50AM Cytokinetics' (CYTK) Initiation of CK-2127107 Phase I is Positive Development - Roth
Mar 27, 2014 10:27AM Applied Genetic Technologies (AGTC) IPO Opens Higher
Mar 27, 2014 10:21AM Alt-Energy Names Show Early Gains (FCEL)(BLDP) (PLUG)
Mar 27, 2014 10:07AM Roth Starts Active Power (ACPW) at Buy; Refocused Company Should See N-T Gains
Mar 27, 2014 08:17AM Applied Genetic Technologies (AGTC) IPO Prices at $12, Below Range
Mar 27, 2014 06:33AM Roth Capital Starts Active Power (ACPW) at Buy
Mar 26, 2014 06:56PM AGTC Announces Pricing of Initial Public Offering
Mar 26, 2014 12:29PM RGS Energy's (RGSE) New Financing Strategy Could Provide Upside; Roth Boosts PT to $6
Mar 26, 2014 08:17AM American Apparel (APP) Prices 61M Common Offering at 50c/Share
Mar 25, 2014 10:34AM Notable Analyst Rating Changes 03/25: (SOL) (RAX) (PCAR) Upgraded; (HIMX) (PHM) (ACI) Downgraded
Mar 25, 2014 09:27AM Pre-Open Stock Movers 3/25: (GALT) (ECYT) (RAX) Higher; (IDN) (HIMX) (GIII) Lower (more...)
Mar 25, 2014 08:53AM Roth Upgrades ReneSola (SOL) to Buy; Sees Outperformance Continuing on Strong Differentiation
Mar 25, 2014 08:34AM American Apparel (APP) Commences $30.5M Cmmon Stock Offering
Mar 25, 2014 07:55AM Roth Capital Upgrades Silvercrest Mines (SVLC) to Buy
Mar 25, 2014 06:57AM Roth Capital Upgrades ReneSola Ltd. (SOL) to Buy
Mar 24, 2014 02:56PM Stronger-than-Expected FY13 Results Set Rexahn Pharma (RNN) Up for Promising FY14 - Analyst
Mar 24, 2014 07:46AM Roth Cuts PT on Curis (CRIS) to $9; Erivedge Phase 2 Misses Roche's (RHHBY) Internal Expectations
Mar 21, 2014 07:08AM Palatin Technologies (PTN) is Ready to Soar; Roth Reaffirms 'Buy' Rating
Mar 20, 2014 11:08AM Synta Pharma (SNTA) Positive Trajectory Reinforced by Latest ENCHANT-1 Data - Roth
Mar 20, 2014 09:31AM Roth on Sidelines with Yingli Green Energy (YGE); Leverage Will Continue to Limit Upside
View More Recent Stories View Older Stories